Generics 13

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Ketamine manufacturers

13 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

13 products found

ketamine

Injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19540

Manufacturer usually replies in 4 days

ketamine

Solution for injection 50mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
Canada, FDA, WHO
Manufacturer #16400

Manufacturer usually replies in 8 days

ketamine

Injection 10 mg, 50 mg, 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #28571

Manufacturer usually replies in 1 days

ketamine

Injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21249

Manufacturer usually replies in 6 days

ketamine

Injection 20 mg, 50 mg, 500 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

ketamine

Injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20087

Manufacturer usually replies in 8 days

ketamine

Injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20368

Manufacturer usually replies in 8 days

ketamine

Injection 50 mg/ ml.

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18474

Manufacturer usually replies in 9 days

ketamine

Injection 50mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18175

Manufacturer usually replies in 5 days

ketamine

Solution for injection 50 mg/ml, 10 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Available for
Licensing with supply
Manufacturer #10323

Manufacturer usually replies in 5 days

ketamine

Solution for injection 50 mg - 10 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
PICS
Manufacturer #10242

Manufacturer usually replies in 9 days

ketamine

Injection 50 MG

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19051

Manufacturer usually replies in 14 days

ketamine

Vials, injection 50 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19051

Manufacturer usually replies in 14 days

Ketamine Manufacturers

The NMDA receptor is blocked by ketamine. It's used to start and keep anesthesia going. Dissociative anesthesia, a trance-like state that provides pain relief, amnesia, and sleepiness are examples of anesthesia. Anesthesia with ketamine retains breathing and airway reflexes, promotes heart function, improves blood pressure, and causes moderate bronchodilation. It's utilized for pain and treatment-resistant depression at lower, sub-anesthetic doses. The benefits for depression patients, on the other hand, are just temporary. Ketamine was discovered by Parke Davis Company in 1956 and was licensed for usage in the United States in 1970. Because of its safety, Ketamine was widely utilized for surgical anesthetic throughout the Vietnam War. Ketamine's widespread use has gained it a spot on the WHO's List of Essential Medicines, and it is now available as a generic medicine following the original patent's expiration. The discovery of ketamine's anti-depressive properties is the single most significant advancement in the treatment of depression in over 50 years. Ketamine works by blocking the NMDA receptor, which is an ionotropic glutamate receptor. The S (+) and R (–) stereoisomers of ketamine bind to the NMDA receptor's dizocilpine region with varied and affinity. The S (+) binds to the receptor with a 2- to 3-fold higher affinity than the latter. The NMDAR is inhibited by ketamine via an allosteric region on the receptor. Psychiatric side effects, as well as high blood pressure and nausea, are common. Regular users of high doses of ketamine for recreational purposes are prone to liver and urinary damage. Ketamine is an NMDA receptor antagonist, which accounts for the majority of its activities save the antidepressant effect, the mechanism of which is still being researched and debated.

How does Ketamine Manufacturers work?

Ketamine's application in anaesthesia reflects its properties. It is a popular alternative for short-term operations that do not require muscular relaxation. Ketamine has a different effect on the respiratory and circulatory systems than other anaesthetics. It suppresses respiration far less than most other anaesthetics on the market. Ketamine usually stimulates rather than depresses the circulatory system when administered in anaesthetic doses. Protective airway reflexes are intact, and ketamine anaesthesia can sometimes be administered without any airway protection. Ketamine's psychotomimetic properties limit its adoption; nevertheless, lamotrigine and nimodipine reduce psychotomimetic effects, which can also be counteracted by benzodiazepines or propofol. Ketamine can be used as the sole anaesthetic for simple procedures in children, or as an induction drug followed by a neuromuscular blocker and tracheal intubation. Children with cyanotic heart disease and neuromuscular problems, in particular, are suitable candidates for ketamine anaesthesia.

The Cost of Ketamine

An online search for the wholesale price for sale of Benidipine for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market. Ketamine is available as an intramuscular (IM) or subcutaneous injection in dosages ranging from 75 to 125 mg, and as an insufflation for intranasal use or snorting in strengths ranging from 60 to 250 mg. A consumer must pay USD 168 for a 200ml supply of 10/10ml injectable solution in the United States. A quantity of 2ml ketamine injection containing 50mg/1ml costs roughly USD 0.25 in India.

Navigating our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Ketamine distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance Ketamine suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Ketamine. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Ketamine is already registered in. Manufacturers also have special, and delivery terms.

Establishing Commercial Ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers Ketamine suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Ketamine Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.